ORAL EPITHELIAL DYSPLASIA (OED)
Clinical trials for ORAL EPITHELIAL DYSPLASIA (OED) explained in plain language.
Never miss a new study
Get alerted when new ORAL EPITHELIAL DYSPLASIA (OED) trials appear
Sign up with your email to follow new studies for ORAL EPITHELIAL DYSPLASIA (OED), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to stop mouth lesions before they become cancer
Disease control Not yet recruitingThis early-phase trial tests a drug called CAN1012, which is injected directly into pre-cancerous mouth lesions. The goal is to see if it is safe and can activate the immune system to fight the abnormal cells. The study involves 36 adults with oral epithelial dysplasia who will r…
Matched conditions: ORAL EPITHELIAL DYSPLASIA (OED)
Phase: PHASE1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New trial aims to stop oral lesions from turning into cancer
Disease control Not yet recruitingThis study looks at the best way to treat people with p53-mutant oral dysplasia (abnormal cells in the mouth) and early-stage oral cancer. About 636 adults will be placed into three groups based on their diagnosis and receive either monitoring, surgery, or surgery plus neck disse…
Matched conditions: ORAL EPITHELIAL DYSPLASIA (OED)
Phase: NA • Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC